Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Sab Biotherapeutics Inc (NQ: SABS )
2.950
+0.433
(+17.23%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 28, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
SAB BIO Appoints Lucy To as Chief Financial Officer
July 31, 2024
SAb Biotherapeutics Rebrands as SAB BIO
June 20, 2024
SAB Biotherapeutics Provides SAB-142 Trial Update
April 16, 2024
SAB Biotherapeutics to Present at INNODIA Annual Meeting
April 08, 2024
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
February 23, 2024
SAB Biotherapeutics Announces Executive Leadership Change
February 02, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
||||||||||||||||||||
|